CRISPR/Cas9-mediated Bag-1 Knockout Increased Mesenchymal Characteristics of MCF-7 Cells Via Akt Hyperactivation-mediated Actin Cytoskeleton Remodeling
Overview
Authors
Affiliations
Bag-1 protein is a crucial target in cancer to increase the survival and proliferation of cells. The Bag-1 expression is significantly upregulated in primary and metastatic cancer patients compared to normal breast tissue. Overexpression of Bag-1 decreases the efficiency of conventional chemotherapeutic drugs, whereas Bag-1 silencing enhances the apoptotic efficiency of therapeutics, mostly in hormone-positive breast cancer subtypes. In this study, we generated stable Bag-1 knockout (KO) MCF-7 breast cancer cells to monitor stress-mediated cellular alterations in comparison to wild type (wt) and Bag-1 overexpressing (Bag-1 OE) MCF-7 cells. Validation and characterization studies of Bag-1 KO cells showed different cellular morphology with hyperactive Akt signaling, which caused stress-mediated actin reorganization, focal adhesion decrease and led to mesenchymal characteristics in MCF-7 cells. A potent Akt inhibitor, MK-2206, suppressed mesenchymal transition in Bag-1 KO cells. Similar results were obtained following the recovery of Bag-1 isoforms (Bag-1S, M, or L) in Bag-1 KO cells. The findings of this study emphasized that Bag-1 is a mediator of actin-mediated cytoskeleton organization through regulating Akt activation.
A BAG-1-inhibitory peptide, GO-Pep, suppresses c-Raf activity in cancer.
Tatli O, Cebi E, Turk M, Dingiloglu B, Sezan A, Basturk E Commun Biol. 2025; 8(1):336.
PMID: 40021821 PMC: 11871328. DOI: 10.1038/s42003-024-07419-4.
Kizilboga T, Ozden C, Can N, Onay Ucar E, Dinler Doganay G FEBS Open Bio. 2024; 14(9):1559-1569.
PMID: 39049197 PMC: 11492399. DOI: 10.1002/2211-5463.13843.
Neeb A, Figueiredo I, Bogdan D, Cato L, Stober J, Jimenez-Vacas J Mol Cancer Ther. 2024; 23(6):791-808.
PMID: 38412481 PMC: 11148553. DOI: 10.1158/1535-7163.MCT-23-0354.
Pan M, Solozobova V, Kuznik N, Jung N, Grassle S, Gourain V Cancer Res Commun. 2023; 3(7):1378-1396.
PMID: 37520743 PMC: 10373600. DOI: 10.1158/2767-9764.CRC-23-0111.